The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cabazitaxel in metastatic castration-resistant prostate cancer (mCRPC): Real-life use, effectiveness, safety, and quality of life (QoL) in the FUJI cohort.
 
Stephane Oudard
Honoraria - Bayer; Bristol-Myers Squibb; Eisai; Merck; Novartis; Pfizer
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Merck; Novartis; Pfizer
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Eisai; Merck; Novartis; Pfizer
 
Karim Fizazi
Honoraria - Amgen; Astellas Pharma; Janssen; Merck; Sanofi; Takeda
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Clovis Oncology; Curevac; ESSA; Janssen Oncology; Orion; Roche/Genentech; Sanofi
Travel, Accommodations, Expenses - Amgen
 
Florence Joly
Consulting or Advisory Role - AstraZeneca; BMS Brazil; Janssen; Novartis; Roche; Sanofi; Tesaro
Research Funding - Astellas Pharma; Janssen
Travel, Accommodations, Expenses - AstraZeneca; Janssen; Roche; tesaro
 
Florence Tubach
No Relationships to Disclose
 
Magali Rouyer
No Relationships to Disclose
 
Stéphanie Lamarque
No Relationships to Disclose
 
Estelle Guiard
No Relationships to Disclose
 
Aurélie Balestra
No Relationships to Disclose
 
Clémentine Lacueille
No Relationships to Disclose
 
Jérémy Jové
No Relationships to Disclose
 
Cécile Droz-Perroteau
No Relationships to Disclose
 
Annie Fourrier-Réglat
No Relationships to Disclose
 
Nicholas Moore
Consulting or Advisory Role - Merck Serono
Research Funding - Aptalis (Inst); AstraZeneca (Inst); Bayer (Inst); Biogen (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Janssen (Inst); Janssen-Cilag (Inst); Lundbeck (Inst); Merck (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); RTI Health Solutions (Inst); Sanofi/Aventis (Inst); Stallergenes (Inst)